Suppr超能文献

κ-阿片受体选择性二羧酸酯衍生萨维林 A 配体。

Kappa-opioid receptor-selective dicarboxylic ester-derived salvinorin A ligands.

机构信息

Department of Pharmacognosy and Research Institute of Pharmaceutical Sciences, School of Pharmacy, University of Mississippi, University, MS 38677-1848, USA.

出版信息

Bioorg Med Chem Lett. 2013 May 15;23(10):2860-2. doi: 10.1016/j.bmcl.2013.03.111. Epub 2013 Apr 4.

Abstract

Salvinorin A, the active ingredient of the hallucinogenic plant Salvia divinorum is the most potent known naturally occurring hallucinogen and is a selective κ-opioid receptor agonist. To better understand the ligand-receptor interactions, a series of dicarboxylic ester-type of salvinorin A derivatives were synthesized and evaluated for their binding affinity at κ-, δ- and μ-opioid receptors. Most of the analogues show high affinity to the κ-opioid receptor. Methyl malonyl derivative 4 shows the highest binding affinity (Ki=2nM), analogues 5, 7, and 14 exhibit significant affinity for the κ-receptor (Ki=21, 36 and 39nM).

摘要

紫堇醇灵 A 是致幻植物墨西哥鼠尾草中的活性成分,是目前已知作用最强的天然致幻剂,也是一种选择性 κ-阿片受体激动剂。为了更好地了解配体-受体相互作用,我们合成了一系列二羧酸酯型紫堇醇灵 A 衍生物,并评估了它们在 κ-、δ-和 μ-阿片受体上的结合亲和力。大多数类似物对 κ-阿片受体具有高亲和力。其中,丙二酰基衍生物 4 表现出最高的结合亲和力(Ki=2nM),类似物 5、7 和 14 对 κ-受体也具有显著的亲和力(Ki=21、36 和 39nM)。

相似文献

1
Kappa-opioid receptor-selective dicarboxylic ester-derived salvinorin A ligands.
Bioorg Med Chem Lett. 2013 May 15;23(10):2860-2. doi: 10.1016/j.bmcl.2013.03.111. Epub 2013 Apr 4.
4
A unique natural selective kappa-opioid receptor agonist, salvinorin A, and its roles in human therapeutics.
Phytochemistry. 2017 May;137:9-14. doi: 10.1016/j.phytochem.2017.02.001. Epub 2017 Feb 10.
5
Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist.
Proc Natl Acad Sci U S A. 2002 Sep 3;99(18):11934-9. doi: 10.1073/pnas.182234399. Epub 2002 Aug 21.
6
Potential anxiolytic- and antidepressant-like effects of salvinorin A, the main active ingredient of Salvia divinorum, in rodents.
Br J Pharmacol. 2009 Jul;157(5):844-53. doi: 10.1111/j.1476-5381.2009.00230.x. Epub 2009 May 5.
8
A review of salvinorin analogs and their kappa-opioid receptor activity.
Bioorg Med Chem Lett. 2018 May 15;28(9):1436-1445. doi: 10.1016/j.bmcl.2018.03.029. Epub 2018 Mar 12.
9
Synthesis and κ-opioid receptor activity of furan-substituted salvinorin A analogues.
J Med Chem. 2014 Dec 26;57(24):10464-75. doi: 10.1021/jm501521d. Epub 2014 Dec 9.
10
Neuropharmacology of the naturally occurring kappa-opioid hallucinogen salvinorin A.
Pharmacol Rev. 2011 Jun;63(2):316-47. doi: 10.1124/pr.110.003244. Epub 2011 Mar 28.

引用本文的文献

1
Emerging Psychotropic Drug for the Treatment of Trigeminal Pain: Salvinorin A.
Pharmaceuticals (Basel). 2024 Nov 30;17(12):1619. doi: 10.3390/ph17121619.
2
Efficient and markerless gene integration with SlugCas9-HF in Kluyveromyces marxianus.
Commun Biol. 2024 Jul 2;7(1):797. doi: 10.1038/s42003-024-06487-w.
4
Natural Products for the Treatment of Pain: Chemistry and Pharmacology of Salvinorin A, Mitragynine, and Collybolide.
Biochemistry. 2021 May 11;60(18):1381-1400. doi: 10.1021/acs.biochem.0c00629. Epub 2020 Sep 22.
5
Cutting-Edge Search for Safer Opioid Pain Relief: Retrospective Review of Salvinorin A and Its Analogs.
Front Psychiatry. 2019 Mar 27;10:157. doi: 10.3389/fpsyt.2019.00157. eCollection 2019.
6
A review of salvinorin analogs and their kappa-opioid receptor activity.
Bioorg Med Chem Lett. 2018 May 15;28(9):1436-1445. doi: 10.1016/j.bmcl.2018.03.029. Epub 2018 Mar 12.
8
Clerodane diterpenes: sources, structures, and biological activities.
Nat Prod Rep. 2016 Oct 28;33(10):1166-226. doi: 10.1039/c5np00137d. Epub 2016 Jul 18.
9
Salvinorin A analogues PR-37 and PR-38 attenuate compound 48/80-induced itch responses in mice.
Br J Pharmacol. 2015 Sep;172(17):4331-41. doi: 10.1111/bph.13212. Epub 2015 Jul 14.
10
Michael acceptor approach to the design of new salvinorin A-based high affinity ligands for the kappa-opioid receptor.
Eur J Med Chem. 2014 Oct 6;85:818-29. doi: 10.1016/j.ejmech.2014.07.077. Epub 2014 Aug 23.

本文引用的文献

1
Semisynthetic neoclerodanes as kappa opioid receptor probes.
Bioorg Med Chem. 2012 May 1;20(9):3100-10. doi: 10.1016/j.bmc.2012.02.040. Epub 2012 Mar 1.
2
Structure of the human κ-opioid receptor in complex with JDTic.
Nature. 2012 Mar 21;485(7398):327-32. doi: 10.1038/nature10939.
3
Differential signaling properties at the kappa opioid receptor of 12-epi-salvinorin A and its analogues.
Bioorg Med Chem Lett. 2012 Jan 15;22(2):1023-6. doi: 10.1016/j.bmcl.2011.11.128. Epub 2011 Dec 7.
4
Neuropharmacology of the naturally occurring kappa-opioid hallucinogen salvinorin A.
Pharmacol Rev. 2011 Jun;63(2):316-47. doi: 10.1124/pr.110.003244. Epub 2011 Mar 28.
5
Opioid receptor probes derived from cycloaddition of the hallucinogen natural product salvinorin A.
J Nat Prod. 2011 Apr 25;74(4):718-26. doi: 10.1021/np1007872. Epub 2011 Feb 21.
6
Synthesis and biological evaluation of C-2 halogenated analogs of salvinorin A.
Bioorg Med Chem Lett. 2010 Oct 1;20(19):5749-52. doi: 10.1016/j.bmcl.2010.08.001. Epub 2010 Aug 5.
8
Convenient synthesis and in vitro pharmacological activity of 2-thioanalogs of salvinorins A and B.
Bioorg Med Chem Lett. 2007 Apr 15;17(8):2229-32. doi: 10.1016/j.bmcl.2007.01.100. Epub 2007 Feb 2.
9
Synthesis and in vitro pharmacological studies of new C(4)-modified salvinorin A analogues.
Bioorg Med Chem Lett. 2006 Nov 1;16(21):5498-502. doi: 10.1016/j.bmcl.2006.08.051. Epub 2006 Aug 30.
10
Synthesis of salvinorin A analogues as opioid receptor probes.
J Nat Prod. 2006 Jun;69(6):914-8. doi: 10.1021/np060094b.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验